The FDA has approved Rybelsus, the first oral GLP-1 receptor agonist, to reduce cardiovascular risk in type 2 diabetes patients. The drug can be prescribed to reduce major adverse cardiovascular issues even in patients who have not yet experienced these events.

The U.S. Food and Drug Administration announced it will relax certain rules for approving low-cost versions of some high-priced medications to reduce costs.

The FDA’s effort to expedite reviews for drugs in line with the Trump administration’s priorities was greeted warmly by a pharmaceutical industry interested in moving approvals more quickly, but raised concerns about the scope of the plan in light of recent cuts at the agency.

Federal regulators are trying to make it easier to develop cheaper alternatives to powerful drugs that many Americans depend on to treat autoimmune diseases or cancers.

Food and Drug Administration has warned four companies that it plans to take enforcement action over their sale of unapproved fluoride-based prescription drugs for children, the agency said on Friday.

The FDA is planning to speed approvals of highly similar copies of expensive biologic drugs, the latest effort in President Donald Trump’s aggressive agenda to lower costs for medicines in the US.

The outbreak includes Texas and is tied to recalled pasta meals sold at grocery stores including Walmart, Trader Joe’s and Kroger.

The Trump administration is proposing changes to Food and Drug Administration guidelines that would make it less expensive for drugmakers to develop biosimilar medicines, the copycat versions of off-patent biologic drugs.

A federal judge is set to decide whether the Trump administration will have to find funds to keep SNAP benefits flowing. And, President Trump says the U.S. should resume nuclear weapons testing.

Texas Attorney General Ken Paxton alleged Johnson & Johnson deceptively marketed the drug as safe for pregnant Texans.